Verve Therapeutics, Inc. (VERV)

Verve Therapeutics Revenue

Verve Therapeutics had revenue of $16.05M in the twelve months ending March 31, 2024, with 379.79% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.70M with 305.63% year-over-year growth. In the year 2023, Verve Therapeutics had annual revenue of $11.76M with 505.77% growth.

• Revenue (ttm): $16.05M
• Revenue Growth: +379.79%
• P/S Ratio: 29.34
• Revenue / Employee: $62,937
• Employees: 255
• Market Cap: 470.90M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	11.76M	9.82M	505.77%
Dec 31, 2022	1.94M	-	-
Dec 31, 2021	0	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.